{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:00:11Z","timestamp":1780556411084,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#148443"],"award-info":[{"award-number":["#148443"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Moderate to severe traumatic brain injury (TBI) is associated with high rates of mortality and long-term disability. Accurate biomarkers are needed to predict longterm neurological outcomes and guide decision-making early after TBI. Neurofilament light chain (NfL), a structural protein of neurons, has emerged as a promising candidate, but its association with outcomes in this population remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis to assess the association between blood or cerebrospinal fluid NfL concentrations and outcomes in adults with moderate to severe TBI. We searched MEDLINE, Embase, Cochrane CENTRAL and Web of Science from inception to October 2025. Eligible studies included cohort studies or randomized controlled trials reporting NfL levels measured during the acute phase and reporting at least one outcome of interest. Our primary outcome was long-term neurological function, defined as the latest available Glasgow Outcome Scale (GOS) or Glasgow Outcome Scale\u2013Extended (GOS-E) score, dichotomized into unfavorable (GOS\u2009\u2264\u20093 or GOS-E\u2009\u2264\u20094) and favorable (GOS\u2009&gt;\u20093 or GOS-E\u2009&gt;\u20094). Mortality, at any time point, was a secondary outcome. Risk of bias was assessed using an adapted scale from the QUADAS-2 tool, and certainty of evidence was evaluated using GRADE criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fourteen studies (2,905 participants) were included, with ten (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091,648) contributing to the meta-analysis for our primary outcome. Higher NfL concentrations were associated with unfavorable neurological outcomes, with moderately higher levels in patients with poor outcomes compared with those with favorable outcomes (SMD 0.45, 95% CI 0.33\u20130.56; I\u00b2 = 12%). Six studies (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009483) assessed mortality; higher NfL concentrations were associated with increased mortality (SMD 0.71, 95% CI 0.04\u20131.39; I\u00b2 = 82%), with a more consistent association when NfL was measured within 24\u00a0h after injury (I\u00b2 = 0%). The certainty of evidence was graded as very low for both outcomes, reflecting risk of bias and, for mortality, additional inconsistency and imprecision.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher NfL concentrations were associated with unfavorable neurological outcomes after moderate-to-severe TBI. The association with mortality was more uncertain and should be interpreted with caution given the substantial heterogeneity across studies. Its incremental prognostic value beyond known predictors remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>PROSPERO CRD42022332110, 22 May 2022.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-026-06036-3","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:46:14Z","timestamp":1777902374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between neurofilament light chain concentrations and outcomes in patients with moderate to severe traumatic brain injury: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"30","author":[{"given":"Marwan","family":"Bouras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Pageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Aur\u00e8le","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Costerousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolanne","family":"Demers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Grenier-Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chartelin Jean","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas Hayg","family":"Torkomyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lauzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Zarychanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Francoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gerges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godwill","family":"Abiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane W.","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis F.","family":"Turgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Canadian Traumatic Brain Injury Research Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"11","key":"6036_CR1","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","volume":"21","author":"AIR Maas","year":"2022","unstructured":"Maas AIR, Menon DK, Manley GT, et al. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurol. 2022;21(11):1004\u201360. https:\/\/doi.org\/10.1016\/S1474-4422(22)00309-X.","journal-title":"Lancet Neurol"},{"issue":"4","key":"6036_CR2","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/CCM.0b013e318275d046","volume":"41","author":"AF Turgeon","year":"2013","unstructured":"Turgeon AF, Lauzier F, Burns KEA, et al. Determination of neurologic prognosis and clinical decision making in adult patients with severe traumatic brain injury: a survey of Canadian intensivists, neurosurgeons, and neurologists. Crit Care Med. 2013;41(4):1086\u201393. https:\/\/doi.org\/10.1097\/CCM.0b013e318275d046.","journal-title":"Crit Care Med"},{"issue":"10","key":"6036_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1089\/neu.2008.0599","volume":"25","author":"GA Zitnay","year":"2008","unstructured":"Zitnay GA, Zitnay KM, Povlishock JT, et al. Traumatic brain injury research priorities: the Conemaugh International Brain Injury Symposium. J Neurotrauma. 2008;25(10):1135\u201352. https:\/\/doi.org\/10.1089\/neu.2008.0599.","journal-title":"J Neurotrauma"},{"issue":"3","key":"6036_CR4","doi-asserted-by":"publisher","first-page":"E371","DOI":"10.9778\/cmajo.20150061","volume":"4","author":"E Mercier","year":"2016","unstructured":"Mercier E, Boutin A, Shemilt M, et al. Predictive value of neuron-specific enolase for prognosis in patients with moderate or severe traumatic brain injury: a systematic review and meta-analysis. CMAJ Open. 2016;4(3):E371\u201382. https:\/\/doi.org\/10.9778\/cmajo.20150061.","journal-title":"CMAJ Open"},{"key":"6036_CR5","doi-asserted-by":"publisher","first-page":"f1757","DOI":"10.1136\/bmj.f1757","volume":"346","author":"E Mercier","year":"2013","unstructured":"Mercier E, Boutin A, Lauzier F, et al. Predictive value of S-100 protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis. BMJ. 2013;346:f1757\u2013f1757. https:\/\/doi.org\/10.1136\/bmj.f1757.","journal-title":"BMJ"},{"issue":"6","key":"6036_CR6","doi-asserted-by":"publisher","first-page":"e522","DOI":"10.1097\/CCM.0000000000003728","volume":"47","author":"M Shemilt","year":"2019","unstructured":"Shemilt M, Boutin A, Lauzier F, et al. Prognostic value of glial fibrillary acidic protein in patients with moderate and severe traumatic brain injury: a systematic review and meta-analysis. Crit Care Med. 2019;47(6):e522\u20139. https:\/\/doi.org\/10.1097\/CCM.0000000000003728.","journal-title":"Crit Care Med"},{"issue":"5","key":"6036_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","volume":"20","author":"M Khalil","year":"2024","unstructured":"Khalil M, Teunissen CE, Lehmann S, et al. Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application. Nat Rev Neurol. 2024;20(5):269\u201387. https:\/\/doi.org\/10.1038\/s41582-024-00955-x.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"6036_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel C, Van Wieringen WN, Zetterberg H, et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019;76(9):1035. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1534.","journal-title":"JAMA Neurol"},{"issue":"1","key":"6036_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14612-6","volume":"11","author":"M Khalil","year":"2020","unstructured":"Khalil M, Pirpamer L, Hofer E, et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun. 2020;11(1):812. https:\/\/doi.org\/10.1038\/s41467-020-14612-6.","journal-title":"Nat Commun"},{"issue":"4","key":"6036_CR10","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3233\/JAD-190615","volume":"72","author":"SY Wang","year":"2019","unstructured":"Wang SY, Chen W, Xu W, et al. Neurofilament light chain in cerebrospinal fluid and blood as a biomarker for neurodegenerative diseases: a systematic review and meta-analysis. J Alzheimers Dis. 2019;72(4):1353\u201361. https:\/\/doi.org\/10.3233\/JAD-190615.","journal-title":"J Alzheimers Dis"},{"issue":"613","key":"6036_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg9922","volume":"13","author":"NSN Graham","year":"2021","unstructured":"Graham NSN, Zimmerman KA, Moro F, et al. Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury. Sci Transl Med. 2021;13(613):eabg9922. https:\/\/doi.org\/10.1126\/scitranslmed.abg9922.","journal-title":"Sci Transl Med"},{"key":"6036_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00300","volume":"8","author":"EP Thelin","year":"2017","unstructured":"Thelin EP, Zeiler FA, Ercole A, et al. Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review. Front Neurol. 2017;8:300. https:\/\/doi.org\/10.3389\/fneur.2017.00300.","journal-title":"Front Neurol"},{"issue":"38","key":"6036_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022363","volume":"99","author":"W Gao","year":"2020","unstructured":"Gao W, Zhang Z, Lv X, et al. Neurofilament light chain level in traumatic brain injury: a system review and meta-analysis. Medicine (Baltimore). 2020;99(38):e22363. https:\/\/doi.org\/10.1097\/MD.0000000000022363.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"6036_CR14","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00068-021-01693-1","volume":"48","author":"E Karantali","year":"2022","unstructured":"Karantali E, Kazis D, McKenna J, Chatzikonstantinou S, Petridis F, Mavroudis I. Neurofilament light chain in patients with a concussion or head impacts: a systematic review and meta-analysis. Eur J Trauma Emerg Surg. 2022;48(3):1555\u201367. https:\/\/doi.org\/10.1007\/s00068-021-01693-1.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"6036_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins JPT, Thomas J, Chandler J, et al.","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. 1st ed. Wiley; 2019. https:\/\/doi.org\/10.1002\/9781119536604.","edition":"1st ed"},{"key":"6036_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"7905","key":"6036_CR17","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0140-6736(75)92830-5","volume":"305","author":"B Jennett","year":"1975","unstructured":"Jennett B. ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale. Lancet. 1975;305(7905):480\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(75)92830-5.","journal-title":"Lancet"},{"issue":"4","key":"6036_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/jnnp.44.4.285","volume":"44","author":"B Jennett","year":"1981","unstructured":"Jennett B, Snoek J, Bond MR, Brooks N. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry. 1981;44(4):285\u201393. https:\/\/doi.org\/10.1136\/jnnp.44.4.285.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"6036_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"issue":"4","key":"6036_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1197\/jamia.M1752","volume":"12","author":"NL Wilczynski","year":"2005","unstructured":"Wilczynski NL, Haynes RB. Optimal search strategies for detecting clinically sound prognostic studies in EMBASE: an analytic survey. J Am Med Inform Assoc. 2005;12(4):481\u20135. https:\/\/doi.org\/10.1197\/jamia.M1752.","journal-title":"J Am Med Inform Assoc"},{"key":"6036_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40\u20136. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.01.021.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"6036_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009.","journal-title":"Ann Intern Med"},{"issue":"6","key":"6036_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","volume":"18","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18(6):805\u201335. https:\/\/doi.org\/10.1097\/EDE.0b013e3181577511.","journal-title":"Epidemiology"},{"key":"6036_CR24","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"2013","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. 0 ed. Routledge; 2013. https:\/\/doi.org\/10.4324\/9780203771587.","edition":"0 ed"},{"key":"6036_CR25","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20f13681","author":"C Andrade","year":"2020","unstructured":"Andrade C. Mean difference, Standardized Mean Difference (SMD), and their use in meta-analysis: as simple as it gets. J Clin Psychiatry. 2020. https:\/\/doi.org\/10.4088\/JCP.20f13681.","journal-title":"J Clin Psychiatry"},{"issue":"7414","key":"6036_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"issue":"4","key":"6036_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"6036_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00134-024-07324-8","volume":"50","author":"C Robba","year":"2024","unstructured":"Robba C, Graziano F, Picetti E, et al. Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes-an analysis of CENTER-TBI data. Intensive Care Med. 2024;50(3):371\u201384. https:\/\/doi.org\/10.1007\/s00134-024-07324-8.","journal-title":"Intensive Care Med"},{"issue":"21\u201322","key":"6036_CR29","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1089\/neu.2023.0029","volume":"40","author":"S Richter","year":"2023","unstructured":"Richter S, Czeiter E, Amrein K, et al. Prognostic value of serum biomarkers in patients with moderate-severe traumatic brain injury, differentiated by Marshall computer tomography classification. J Neurotrauma. 2023;40(21\u201322):2297\u2013310. https:\/\/doi.org\/10.1089\/neu.2023.0029.","journal-title":"J Neurotrauma"},{"issue":"1","key":"6036_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep36791","volume":"6","author":"P Shahim","year":"2016","unstructured":"Shahim P, Gren M, Liman V, et al. Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci Rep. 2016;6(1):36791. https:\/\/doi.org\/10.1038\/srep36791.","journal-title":"Sci Rep"},{"issue":"5","key":"6036_CR31","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1089\/neu.2016.4496","volume":"34","author":"J Ljungqvist","year":"2017","unstructured":"Ljungqvist J, Zetterberg H, Mitsis M, Blennow K, Skoglund T. Serum neurofilament light protein as a marker for diffuse axonal injury: results from a case series study. J Neurotrauma. 2017;34(5):1124\u20137. https:\/\/doi.org\/10.1089\/neu.2016.4496.","journal-title":"J Neurotrauma"},{"issue":"20","key":"6036_CR32","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1089\/neu.2019.6375","volume":"36","author":"E Thelin","year":"2019","unstructured":"Thelin E, Al Nimer F, Frostell A, et al. A serum protein biomarker panel improves outcome prediction in human traumatic brain injury. J Neurotrauma. 2019;36(20):2850\u201362. https:\/\/doi.org\/10.1089\/neu.2019.6375.","journal-title":"J Neurotrauma"},{"issue":"7","key":"6036_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132177","volume":"10","author":"F Al Nimer","year":"2015","unstructured":"Al Nimer F, Thelin E, Nystr\u00f6m H, et al. Comparative assessment of the prognostic value of biomarkers in traumatic brain injury reveals an independent role for serum levels of neurofilament light. PLoS One. 2015;10(7):e0132177. https:\/\/doi.org\/10.1371\/journal.pone.0132177.","journal-title":"PLoS One"},{"key":"6036_CR34","first-page":"A25","volume":"38","author":"C Lynch","year":"2021","unstructured":"Lynch C, Yue J, Schneider A, Manley G, Diaz-Arrastia R. Systemic inflammatory cytokines improve upon prognostication of neurodegenerative biomarkers for poor outcome following TBI. J Neurotrauma. 2021;38:A25\u20136. MARY ANN LIEBERT, INC 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA.","journal-title":"J Neurotrauma"},{"issue":"3","key":"6036_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s12028-024-01998-0","volume":"41","author":"E Andersson","year":"2024","unstructured":"Andersson E, \u00d6st M, Dalla K, Zetterberg H, Blennow K, Nellg\u00e5rd B. Acute-phase neurofilament light and glial fibrillary acidic proteins in cerebrospinal fluid predict long-term outcome after severe traumatic brain injury. Neurocrit Care. 2024;41(3):813\u201327. https:\/\/doi.org\/10.1007\/s12028-024-01998-0.","journal-title":"Neurocrit Care"},{"issue":"3","key":"6036_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/neurosci4030015","volume":"4","author":"FC Buh","year":"2023","unstructured":"Buh FC, Taiwe GS, Kobeissy FH, et al. Serum biomarker concentrations upon admission in acute traumatic brain injury: associations with TBI severity, Toxoplasma gondii infection, and outcome in a referral hospital setting in Cameroon. NeuroSci. 2023;4(3):164\u201377. https:\/\/doi.org\/10.3390\/neurosci4030015.","journal-title":"NeuroSci"},{"issue":"7","key":"6036_CR37","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.21554","volume":"6","author":"F Gonzalez-Ortiz","year":"2023","unstructured":"Gonzalez-Ortiz F, Dulewicz M, Ashton NJ, et al. Association of serum brain-derived tau with clinical outcome and longitudinal change in patients with severe traumatic brain injury. JAMA Netw Open. 2023;6(7):e2321554. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.21554.","journal-title":"JAMA Netw Open"},{"issue":"1\u20132","key":"6036_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/neu.2023.0120","volume":"41","author":"O Korhonen","year":"2024","unstructured":"Korhonen O, Mononen M, Mohammadian M, et al. Outlier analysis for acute blood biomarkers of moderate and severe traumatic brain injury. J Neurotrauma. 2024;41(1\u20132):91\u2013105. https:\/\/doi.org\/10.1089\/neu.2023.0120.","journal-title":"J Neurotrauma"},{"issue":"3\u20134","key":"6036_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/neu.2023.0207","volume":"41","author":"J Tuure","year":"2024","unstructured":"Tuure J, Mohammadian M, Tenovuo O, et al. Late blood levels of neurofilament light correlate with outcome in patients with traumatic brain injury. J Neurotrauma. 2024;41(3\u20134):359\u201368. https:\/\/doi.org\/10.1089\/neu.2023.0207.","journal-title":"J Neurotrauma"},{"issue":"13\u201314","key":"6036_CR40","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1089\/neu.2023.0449","volume":"41","author":"KKW Wang","year":"2024","unstructured":"Wang KKW, Barton DJ, McQuillan LE, et al. Parallel cerebrospinal fluid and serum temporal profile assessment of axonal injury biomarkers Neurofilament-Light Chain and Phosphorylated Neurofilament-Heavy Chain: associations with patient outcome in moderate-severe traumatic brain injury. J Neurotrauma. 2024;41(13\u201314):1609\u201327. https:\/\/doi.org\/10.1089\/neu.2023.0449.","journal-title":"J Neurotrauma"},{"key":"6036_CR41","doi-asserted-by":"publisher","unstructured":"Pasupuleti S, Sharma A, Yerramneni VK, Reddy R. Neurobiomarkers for Traumatic Brain Injury: Comparison of Serum Values Within 24 Hours of Injury With Glasgow Coma Scale (GCS) Scores in a Prospective Cohort Trial. Cureus Published online May. 2025;31. https:\/\/doi.org\/10.7759\/cureus.85152.","DOI":"10.7759\/cureus.85152"},{"issue":"1","key":"6036_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03220-z","volume":"23","author":"SL Wang","year":"2023","unstructured":"Wang SL, Li N, Feng SY, Li Y. Serum neurofilament light chain as a predictive marker of neurologic outcome after cardiac arrest: a meta-analysis. BMC Cardiovasc Disord. 2023;23(1):193. https:\/\/doi.org\/10.1186\/s12872-023-03220-z.","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"6036_CR43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31301","volume":"14","author":"CD Farragher","year":"2022","unstructured":"Farragher CD, Ku Y, Powers JE. The potential role of neurofilament light in mild traumatic brain injury diagnosis: a systematic review. Cureus. 2022;14(11):e31301. https:\/\/doi.org\/10.7759\/cureus.31301.","journal-title":"Cureus"},{"issue":"6","key":"6036_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104813","volume":"29","author":"D Liu","year":"2020","unstructured":"Liu D, Chen J, Wang X, Xin J, Cao R, Liu Z. Serum neurofilament light chain as a predictive biomarker for ischemic stroke outcome: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2020;29(6):104813. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104813.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9","key":"6036_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290619","volume":"18","author":"Y Fu","year":"2023","unstructured":"Fu Y, Fan XT, Li H, et al. Neuroprognostication value of serum neurofilament light chain for out-of-hospital cardiac arrest: a systematic review and meta-analysis. PLoS One. 2023;18(9):e0290619. https:\/\/doi.org\/10.1371\/journal.pone.0290619.","journal-title":"PLoS One"},{"key":"6036_CR46","doi-asserted-by":"publisher","unstructured":"Lin CH, Li CH, Yang KC, et al. Blood NfL: A biomarker for disease severity and progression in Parkinson disease. Neurology. 2019;93(11). https:\/\/doi.org\/10.1212\/WNL.0000000000008088.","DOI":"10.1212\/WNL.0000000000008088"},{"issue":"2","key":"6036_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/ene.14063","volume":"27","author":"E Thouvenot","year":"2020","unstructured":"Thouvenot E, Demattei C, Lehmann S, et al. Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis. Eur J Neurol. 2020;27(2):251\u20137. https:\/\/doi.org\/10.1111\/ene.14063.","journal-title":"Eur J Neurol"},{"issue":"9","key":"6036_CR48","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/acn3.50872","volume":"6","author":"D Jakimovski","year":"2019","unstructured":"Jakimovski D, Kuhle J, Ramanathan M, et al. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study. Ann Clin Transl Neurol. 2019;6(9):1757\u201370. https:\/\/doi.org\/10.1002\/acn3.50872.","journal-title":"Ann Clin Transl Neurol"}],"updated-by":[{"DOI":"10.1186\/s13054-026-06117-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000}}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06036-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06036-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06036-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:05:59Z","timestamp":1780553159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06036-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6036"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06036-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13054-026-06117-3","URL":"https:\/\/doi.org\/10.1186\/s13054-026-06117-3","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}